Evidence map›Paper›PMID 37292001›Full record

ArticleImmunotherapy2023

Evaluation of appendectomy as a potential risk factor for immune checkpoint inhibitor-associated enterocolitis.

Nira A Krasnow, Donald F Chute, Ayo S Falade, Crystal M North, Kerry L Reynolds, Michael L Dougan

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Immunotherapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Nira A KrasnowHarvard Medical School, Boston, MA 02115, USA.
Donald F ChuteDepartment of Vascular Surgery, UMass Memorial Medical Center, Worcester, MA 01605, USA.
Ayo S FaladeDepartment of Medicine, Mass General Brigham Salem Hospital, Salem, MA 01970, USA.
Crystal M NorthHarvard Medical School, Boston, MA 02115, USA.
Kerry L ReynoldsHarvard Medical School, Boston, MA 02115, USA.
Michael L DouganHarvard Medical School, Boston, MA 02115, USA.ORCID 0000-0001-9266-2009
Harvard University · USSalem Hospital · USUMass Memorial Health Care · US

Funding

Strategies for Receptor inhibition in immunotherapyR01CA177684 · NCI · STANFORD UNIVERSITY · PI DOUGAN, MICHAEL LAWRENCE, GARCIA, KENAN CHRISTOPHER · 2014 to 2025
$3.5M
Molecular Pathways Regulating Tissue-resident Memory T cells in the GutR01AI169188 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Michael Lawrence Dougan · 2022 to 2026
$3.0M
Regulation of brown fat metabolism by the immune receptor PD-L1K08DK114563 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI DOUGAN, MICHAEL LAWRENCE · 2017 to 2021
$868k
NCI NIH HHS R01 CA177684NIAID NIH HHS R01 AI169188NIDDK NIH HHS K08 DK114563
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ColitisEnterocolitisAppendectomyHumansImmune Checkpoint InhibitorsRisk FactorsImmune Checkpoint Inhibitorsappendectomyimmune checkpoint inhibitor enterocolitisimmune checkpoint inhibitorsimmune-related adverse events

Identifiers

PMID37292001
PMCPMC10346134
OpenAlexW4379967377

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.